These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1371411)

  • 1. Liposomal encapsulation of azidothymidine results in decreased hematopoietic toxicity and enhanced activity against murine acquired immunodeficiency syndrome.
    Phillips NC; Tsoukas C
    Blood; 1992 Mar; 79(5):1137-43. PubMed ID: 1371411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposomal encapsulation of 3'-azido-3'-deoxythymidine (AZT) results in decreased bone marrow toxicity and enhanced activity against murine AIDS-induced immunosuppression.
    Phillips NC; Skamene E; Tsoukas C
    J Acquir Immune Defic Syndr (1988); 1991; 4(10):959-66. PubMed ID: 1890605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of combination interleukin-3 (IL-3) and granulocyte-macrophage colony stimulating factor (GM-CSF) on hematopoiesis administered to retrovirus-infected immunodeficient mice receiving dose-escalation zidovudine (AZT).
    Gallicchio VS; Hughes NK; Tse KF; Ling J; Gaines H; Bowen TE; Uluitu M
    Int J Immunopharmacol; 1995 Nov; 17(11):865-78. PubMed ID: 8788116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New lipophilic alkyl/acyl dinucleoside phosphates as derivatives of 3'-azido-3'-deoxythymidine: inhibition of HIV-1 replication in vitro and antiviral activity against Rauscher leukemia virus infected mice with delayed treatment regimens.
    Schwendener RA; Gowland P; Horber DH; Zahner R; Schertler A; Schott H
    Antiviral Res; 1994 May; 24(1):79-93. PubMed ID: 7944315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute toxic effects of 3'-azido-3'-deoxythymidine (AZT) on normal and regenerating murine hematopoiesis.
    Scheding S; Media JE; Nakeff A
    Exp Hematol; 1994 Jan; 22(1):60-5. PubMed ID: 8282060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of stem cell factor to ameliorate AZT-induced anemia in immunodeficient mice.
    Hamburger AW; Zsebo K; Chow FP
    Eur J Haematol; 1993 Mar; 50(3):172-8. PubMed ID: 7682517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of zidovudine on Friend virus complex infection in Rfv-3r/s genotype-containing mice used as a model for HIV infection.
    Morrey JD; Warren RP; Okleberry KM; Burger RA; Johnston MI; Sidwell RW
    J Acquir Immune Defic Syndr (1988); 1990; 3(5):500-10. PubMed ID: 2157836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity of erythroid progenitor colonies to erythropoietin in azidothymidine treated immunodeficient mice.
    Chow FP; Sutton PA; Hamburger AW
    Br J Haematol; 1991 Feb; 77(2):139-44. PubMed ID: 2004015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of interleukin-1, GM-CSF, erythropoietin, and lithium on the toxicity associated with 3'-azido-3'-deoxythymidine (AZT) in vitro on hematopoietic progenitors (CFU-GM, CFU-MEG, and BFU-E) using murine retrovirus-infected hematopoietic cells.
    Gallicchio VS; Hughes NK; Hulette BC; Noblitt L
    J Leukoc Biol; 1991 Dec; 50(6):580-6. PubMed ID: 1940611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time-dependent changes induced by azidothymidine in erythroid progenitor colonies in immunodeficient mice.
    Chow FP; Hamburger AW
    Exp Hematol; 1992 Feb; 20(2):245-50. PubMed ID: 1544395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of murine AIDS by alternate administration of azidothymidine and fludarabine monophosphate.
    Fraternale A; Casabianca A; Tonelli A; Vallanti G; Chiarantini L; Brandi G; Celeste AG; Magnani M
    J Acquir Immune Defic Syndr; 2000 Mar; 23(3):209-20. PubMed ID: 10839656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced hematopoietic toxicity, enhanced cellular uptake and altered pharmacokinetics of azidothymidine loaded galactosylated liposomes.
    Garg M; Jain NK
    J Drug Target; 2006 Jan; 14(1):1-11. PubMed ID: 16603446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3'-Azido-3'-deoxythymidine prevents induction of murine acquired immunodeficiency syndrome in C57BL/10 mice infected with LP-BM5 murine leukemia viruses, a possible animal model for antiretroviral drug screening.
    Ohnota H; Okada Y; Ushijima H; Kitamura T; Komuro K; Mizuochi T
    Antimicrob Agents Chemother; 1990 Apr; 34(4):605-9. PubMed ID: 1693056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3'-Azido-3'-deoxythymidine ameliorates the thrombocytopenia observed in a murine model of AIDS.
    Chow FP; Sutton PA; Hamburger AW
    Exp Hematol; 1990 Oct; 18(9):1038-41. PubMed ID: 2168839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different effect of benzylacyclouridine on the toxic and therapeutic effects of azidothymidine in mice.
    Falcone A; Darnowski JW; Ruprecht RM; Chu SH; Brunetti I; Calabresi P
    Blood; 1990 Dec; 76(11):2216-21. PubMed ID: 2257295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo tissue disposition of 3'-azido-3'-deoxythymidine and its anabolites in control and retrovirus-infected mice.
    Chow HH; Li P; Brookshier G; Tang Y
    Drug Metab Dispos; 1997 Apr; 25(4):412-22. PubMed ID: 9107539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additive effect of erythropoietin and heme on murine hematopoietic recovery after azidothymidine treatment.
    Harrison J; Kappas A; Levere RD; Lutton JD; Chertkov JL; Jiang S; Abraham NG
    Blood; 1993 Dec; 82(12):3574-9. PubMed ID: 8260696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of in vivo administration of stem cell factor on thrombopoiesis in normal and immunodeficient mice.
    Chow FP; Zsebo K; Hamburger AW
    Exp Hematol; 1993 Aug; 21(9):1255-62. PubMed ID: 7687220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zidovudine (AZT) reduces virus titer, retards immune dysfunction, and prolongs survival in the LP-BM5 murine induced immunodeficiency model.
    Basham T; Rios CD; Holdener T; Merigan TC
    J Infect Dis; 1990 May; 161(5):1006-9. PubMed ID: 2157768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.